AlphaYouTK
Congress trade
Rep. Thomas Kean (R-NJ) bought $1K-$15K of Abbott Laboratories (ABT) stock
Thomas Kean, U.S. Representative (R-NJ), disclosed a purchase of Abbott Laboratories (ABT) stock worth $1K-$15K in a STOCK Act filing on Jan 22, 2025.
The trade happened on Dec 16, 2024, 37 days before it was made public.
ABT has moved -13.4% since the trade date, from $112.62 to $97.50 (Oct 2, 2026 close).
- Traded
- Dec 16, 2024
- Disclosed
- Jan 22, 2025
- Filing delay
- 37 days
- Price since
- -13.4%
- Source
- STOCK Act disclosure
Other trades in this disclosure (6)
More ABT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.